Search
Prelude Therapeutics Inc
PRLDAdd to Watchlist
4.600USD
-0.450-8.91%
Close 07-31 16:00（ET）Quotes delayed by 15 min
366.37MMarket Cap
LossP/E TTM
PRLD Financials
See Prelude Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Prelude Therapeutics Inc Earnings Date
Latest Release
May 12, 2026
EPS / Forecast
-0.13/-0.25
Revenue / Forecast
4.58M/0.00
Period
FY2025 Earnings
Revenue(YoY)
12.14M
73.43%
EPS(YoY)
-1.29
22.93%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total revenue reached 12.14M, with a year-on-year change of 7.00M.
What are the current assets of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its current assets were 105.69M, with a year-on-year change of -22.23.
What are the total assets of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total assets of Prelude Therapeutics Inc were 141.31M, with a year-on-year change of -19.49.
What are the total liabilities of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total liabilities of Prelude Therapeutics Inc were 72.68M, with a year-on-year change of 64.97.
What is the total equity of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its total equity of Prelude Therapeutics Inc was 68.64M, with a year-on-year change of -47.79.
What is the net operating income of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net operating income of Prelude Therapeutics Inc was -104.57M, with a year-on-year change of 25.16.
What is the net investment of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net investment of Prelude Therapeutics Inc was 53.46M, with a year-on-year change of -40.73.
What is the net financing of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net financing of Prelude Therapeutics Inc was 24.82M, with a year-on-year change of 20780.00.
What is the Earnings Per Share (EPS) of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.29, with a year-on-year change of 22.93.
What is the net income of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net income was -99.50M, with a year-on-year change of 21.76.
What is the net margin of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its net profit margin was -819.59, with a year-on-year change of 54.89.
What is the Return on Equity (ROE) of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -99.45, with a year-on-year change of -44.10.
What is the Return on Assets (ROA) of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -62.81, with a year-on-year change of -11.91.
What is the operating profit of Prelude Therapeutics Inc?
According to Prelude Therapeutics Inc's FY2025 earnings report, its operating profit was -104.57M, with a year-on-year change of 25.16.